Trademark: AKORN 1833553
Word
AKORN
ID
1833553
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
12 September 2016
Registration Date
12 September 2016
Renewal Date
12 September 2026

Service
Refer to WIPO address for Correspondence

Goods and Services:
Class 5:
Pharmaceutical products, namely, vaccines for the prevention of tetanus and diphtheria; opthalmic drugs; analgesics; anesthetics; poison control preparations, namely, poison control antidotes and pharmaceutical preparations for the treatment of poison ingestion; pharmaceutical preparations for the treatment of radiological, nuclear and chemical burns and exposures; pharmaceutical preparations for the treatment of rheumatologic diseases; pharmaceutical products and preparations, namely, inhalants, injectables, nasal sprays and mists, oral liquids, oral solids and topicals for sterile aqueous ophthalmic solutions; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open-angle glaucoma; sterile indocyanine green for use as a cardiac diagnostic aid, a hepatic diagnostic aid and as a retinal diagnostic aid; hypnotic sedative anesthetic compounds; mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; spinal anesthetics; anti-diarrheal agents; controlled prescription synthetic narcotics, namely, codeine and buprenorphine; anxiolytics; anti-seizure medications; topical anesthetics; pharmaceutical preparations for treatment of arsenic, gold and mercury poisoning and acute lead poisoning; pharmaceutical preparations for treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and musculoskeletal conditions; antiviral agents; anti-infectives; vitamins; dietary and nutritional supplements; magnesium supplements; antacids; pharmaceutical preparations for relief of nasal congestion, sinus pressure and sinus headache, nasal sprays; topicals for the treatment of arthritis, joint pain, back pain, foot pain and muscle pain; preparations for the relief of pain; pain relief medication; arthritis and joint pain preparations; cough suppressants and expectorants; cough drops and syrups; preparations for relief of symptoms of common colds and influenza; tablets, swabs, nasal sprays and effervescent preparations for treating colds and flu; tablets, swabs, nasal sprays and effervescent preparations for preventing colds and flu; medicated foot creams, lotions and ointments; medicated skin creams and lotions, including anti-itch creams; medicated tinctures and ointments for lip and skin care; eye drops; lubricant eye drops; eyelid cleanser, skin care around the eyelid; medicated substances for eye health; contact lens comfort drops, veterinary pharmaceuticals; veterinary pharmaceuticals and preparations, namely, xylazine, ketamine, and reversing agents and antagonists for use in horses; veterinary pain relief medications, anesthetics and sedatives; veterinary ophthalmics; veterinary eye wash; veterinary eye lubricants and eye drops